Personalized Medicine for Otolaryngology (ENT)

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 548

Special Issue Editor


E-Mail
Guest Editor
Division of Neurotology and Skull Base Surgery, Department of Otolaryngology-Head & Neck Surgery, University of California, Irvine, CA, USA
Interests: hearing loss; tinnitus; dizziness; Meniere’s disease; artificial intelligence in clinical decision-making processes
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Precision medicine endeavors to combine health sciences, engineering, artificial intelligence, clinical genomics, data science, and public health in order to provide personalized and effective health and wellness strategies. In the last decade, personalized medicine has shifted the traditional “one size/drug fits all” approach into a more stratified therapeutic strategy, which includes prevention, diagnostics, therapy/treatment, and rehabilitation. Personalized medicine aims to change the healthcare landscape, focusing on the individual patient to empirically identify the most effective health and wellness strategies at a personal level. This approach will also assess if the cost of treatments are validated by their utility, as well as opening doors for innovations regarding diseases where no current treatments change the course of the disease, such as head and neck squamous cell carcinoma, tinnitus, or hearing loss.

This Special Issue aims to provide a broad overview of personalized medicine across all subspecialties of otolaryngology, different clinical or basic science methodology, as well as cutting edge therapeutic options, such as gene/stem cell therapy. Moreover, this Special Issue will cover all aspects of personalized treatment or rehabilitation options in the field of otolaryngology and their positive impact on the patient’s survival or quality of life.

Dr. Mehdi Abouzari
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • otology
  • head and neck cancer
  • rhinology
  • laryngology
  • facial plastic surgery
  • sleep medicine
  • biomarker
  • clinical genomics
  • artificial intelligence

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 509 KiB  
Article
Association between Hearing Aid Use and Cognitive Function in Persons with Hearing Impairment Stratified by Cardiovascular Risk
by Kouki Tomida, Sangyoon Lee, Keitaro Makino, Osamu Katayama, Kenji Harada, Masanori Morikawa, Ryo Yamaguchi, Chiharu Nishijima, Kazuya Fujii, Yuka Misu and Hiroyuki Shimada
J. Pers. Med. 2024, 14(5), 479; https://doi.org/10.3390/jpm14050479 - 29 Apr 2024
Viewed by 385
Abstract
The purpose of this study was to conduct a cross-sectional analysis of the association between hearing aid use and cognitive decline in community-dwelling older adults with hearing impairment, stratified by cardiovascular risk level. This cross-sectional study covers 1857 hearing-impaired individuals selected among 10,674 [...] Read more.
The purpose of this study was to conduct a cross-sectional analysis of the association between hearing aid use and cognitive decline in community-dwelling older adults with hearing impairment, stratified by cardiovascular risk level. This cross-sectional study covers 1857 hearing-impaired individuals selected among 10,674 community-dwelling older adults (≥65 years of age) in Japan. We investigate the association between hearing aid use and cognitive decline stratified by cardiovascular risk level, by assessing self-reported hearing impairment and hearing aid use, absolute cardiovascular risk, cognitive function, and potential confounding factors. The association between hearing impairment severity and increased cardiovascular risk, and the benefit of hearing aid use in preventing cognitive decline, were examined in a binomial logistic regression analysis, with the presence of cognitive decline as the objective variable. In the low cardiovascular risk group, hearing aid users had a lower odds ratio for decline in executive function than non-users (odds ratio = 0.61, 95% confidence interval: 0.39–0.98). However, there was no significant association between hearing aid use and cognitive decline in the high cardiovascular risk group (p > 0.05). Among older adults with hearing impairment, hearing aid use was associated with the maintenance of executive function in individuals of low cardiovascular risk. Full article
(This article belongs to the Special Issue Personalized Medicine for Otolaryngology (ENT))
Show Figures

Figure 1

Back to TopTop